Resumen

CARI CHOQUE, Heidy; CARI CHOQUE, Lizeth Jenny; CARI CHOQUE, Nithza Miriam  y  GONZALES CABA, Antonio. The Design Epidemiologist Subsystem Surveillance with the Resistance to the Antimicrobials Kids into smaller five years with Infection Urinary Tract of the Secured SUMI-SPS Laboratory IGBJ 2009-2011. Arch.Boliv.Med. [online]. 2014, vol.22, n.90, pp. 13-18. ISSN 0004-0525.

Observing the vacuum existing in the knowledge of antimicrobial resistance of agents uropathogens antimicrobials to the benefit of urinary tract infection in the empirical treatment in children under five years assured the childish, currently effective mother’s insurance universal in public health insurance. This investigation is now as general, design a subsystem of epidemiological surveillance of antimicrobial resistance uropathogenic benefits urinary infection universal maternal and child safe in children under five, in order to remedy this weakness. The approach to quantitative, longitudinal descriptive, hindsight guy applies, observational character of one hundred positive urine culture and sensitivity of patients under five years with urinary tract infection registered in the microbiology laboratory during 2009-2010-2011, derived from outpatient and hospital care reference. The analysis of the results of the determined resistance ratio calculating required for validity, leads to the following conclusions. Escherichia coli it is the most common etiologic agent of urinary tract infection in the community and in hospitals, followed by Klebsiella spp., and Enterobacter spp, Escherichia coli with more than sixty percent resistance to ampicillin, cephalothin, trimethoprim-sulfamethoxazole and amoxicillin-clavulonato. Also low antimicrobial resistance is determined: Escherichia coli in the community to cefotaxime, cefoxitin, norfloxacin, amikacin, nitrofurantoin and imipenem and hospitals to ciprofloxacin, norfloxacin, amikacin, cefotaxime, nitrofurantoin, cefoxitin, imipenem and meropenem; Klebsiella pneumoniae respond to treatment with: amikacin, cefoxitin and carbapenems and Enterobacter spp. to amikacin, ciprofloxacina, norfloxacina and carbapenemes. All these antimicrobial represent an alternative in therapy of urinary tract infection.

Palabras llave : Resistance; uropathogens; antimicrobials; urinarytractinfection.